Sponsored Links
| Researchers Receive NIH Grant For The Move Toward Clinical Trials Targeting The Lysosomal Storage Disease MPSIIIB |
 |
 |
 |
| Medical News - Lymphology and Lymphedema | |||
|
Investigators at Nationwide Children's have received a grant from the National Institutes of Health (NIH) to help move a therapy for MPS IIIB that has been shown effective in mice toward clinical trials in humans. Mucopolysaccharidosis (MPS) IIIB, also known as Sanfilippo Syndrome B, is a lysososmal storage disease caused by deficiency in the essential enzyme NAGLU... Read more: Lymphology/Lymphedema News From Medical News Today
|